Trasutuzumab versus observation for high-risk, non-metastatic, HER2 non-amplified breast cancer with Circulating Tumor Cells (EORTC 90091-10093 Treat CTC): A European, multicenter, randomized phase 2 trial

著录项

• 来源
  《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2018年第2018期|共1页
• 作者

  Ignatiadis M.; Litiere S.; Rothe F.; Riethdorf S.; Proudhon C.; Fehm T.; Aalders K.; Forstbauer H.; Fasching P.; Brain E.; Vuylsteke P.; Guardiola E.; Lorenz R.; Pantel K.; Tryfonidis K.; Janni W.; Piccart M.; Sotiriou C.; Rack B.; Pierga J. Y.;

  展开▼
• 作者单位

  Inst Jules Bordet Dept Med Oncol Brussels Belgium;

  EORTC Dept Stat Brussels Belgium;

  Univ Libre Bruxelles Breast Canc Translat Res Lab Inst Jules Bordet Brussels Belgium;

  Univ Med Ctr Hamburg Eppendorf Dept Tumor Biol Hamburg Germany;

  Inst Curie Circulating Tumor Biomarker Lab Paris France;

  Univ Klinikum Frauenklin Forschungslab Dusseldorf Germany;

  EORTC Dept Med Brussels Belgium;

  GOSPL Troisdorf Germany;

  Univ Klinikum Erlangen Dept Gynecol &

  Obstet Erlangen Germany;

  Hop Rene Huguenin Inst Curie Dept Med Oncol Paris France;

  CHU UCL Namur Site St Elisabeth Dept Med Oncol Namur Belgium;

  Ctr Hosp Dracenie Dept Med Oncol Draguignan France;

  Dept Gynecol &

  Obstet Braunschweig Germany;

  Univ Med Ctr Hamburg Eppendorf Dept Tumor Biol Hamburg Germany;

  EORTC Dept Med Brussels Belgium;

  Univ Klinikum Ulm Dept Gynecol &

  Obstet Ulm Germany;

  Inst Jules Bordet Dept Med Oncol Brussels Belgium;

  Inst Jules Bordet Dept Med Oncol Brussels Belgium;

  Ludwig Maximilians Univ Munchen Dept Gynecol &

  Obstet Munich Germany;

  Univ Paris 05 Inst Curie Dept Med Oncol Paris France;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词